The European Union has granted market approval to Boston Scientific Corp. for its Confient implantable cardiovascular defibrillator. A U.S. FDA application for the device is pending.
Published in Brief:
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan